- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.09. | AI's Healthcare 'Doomsday'? It May Be Less About Autonomy Than Trust | ||
| 30.09. | AI Won't Fix Social Care, But Could It Help Us Finally Make It Work? | ||
| 30.09. | Tiny Health Secures $33M to Expand Microbiome Testing | ||
| 29.09. | Unite Us, Instacart Link Care Coordination and Grocery Benefits to Scale Food-as-Medicine | ||
| 29.09. | AstraZeneca Places a $2B Bet on a Summit Therapeutics Cancer Drug | ||
| 29.09. | MedCity Pivot Podcast: A Conversation With AliveCor's Priya Abani | ||
| 29.09. | The Illegal Drug Marketplace in Your Patients' Pockets | ||
| 29.09. | DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens | ||
| 29.09. | New Coalition Launches to Expand Direct Contracting | ||
| 28.09. | Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch | ||
| 28.09. | Beyond One-Size-Fits-All: Women, Substance Use, and the Need for Gender-Responsive Care | ||
| 28.09. | Hospital and Payer AI Governance Is at a Crossroads | ||
| 27.09. | Mirum Pharma Pill Lands FDA Approval for Ultra-Rare Bone Growth Disorder | ||
| 27.09. | When AI Gets Medicine Wrong, Who's Liable? | ||
| 27.09. | Fifty Years of Pediatric Rheumatology, but Children Still Can't Access the Treatments They Need | ||
| 27.09. | MedTech Commercialization Gap: Moving Beyond Technical Viability | ||
| 25.09. | Gene Silencing-Biotech ADARx Makes Some Noise With $535M Stock Market Debut | ||
| 25.09. | AI Goes All In To Support Nursing Teams: Ambient Charting is Just the Start | ||
| 24.09. | UHC, Cigna and Centene Sign On to New National Shared Credentialing Program | ||
| 24.09. | Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact | ||
| 24.09. | From OpenNotes to "Doc Can I Record You?" Why Physicians Should Embrace Era of Accountability | ||
| 24.09. | Modernizing Medicare Advantage for the Next Generation of Seniors | ||
| 24.09. | Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease' | ||
| 23.09. | Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device | ||
| 23.09. | Who is Abridge's CEO Shiv Rao? No, Really… |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.